mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.3 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |